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Abstract
Background: Many health care workers (HCWs) are at increased risk for tuberculosis (TB). The World Health
Organization (WHO) recommends screening HCWs for TB in high burden settings but this is often not implemented
in countries with a high TB incidence. We assessed the feasibility of TB screening among HCWs, including
participation rate and yield, as part of a project introducing facility specific TB interventions.
Methods: This study had a cross-sectional design. HCWs (including paid staff and community volunteers) from 13
clinics and two hospitals in the Ndola district of Zambia participated. HCWs were screened by a designated person in
their own facility. The agreed screening algorithm for HCWs included annual symptom screening, with sputum smear,
culture (or Xpert) and chest x-ray offered to HCWs with at least one TB symptom, i.e. those with presumptive TB.
Results: A total of 1011 out of 1619 (62%) staff and 71 out of 138 (51%) community volunteers were screened within
one year, total 1082/1757 (62%). Five percent (52/1082) of those screened were presumptive TB patients. Seventy-three
percent (38/52) of presumptive TB patients received all diagnostic tests according to the agreed algorithm. Eighteen
out of 1757 staff and volunteers combined were diagnosed with TB within a calendar year, showing a notified TB
incidence of 1%. At least five of them were diagnosed during the screening appointment (0.5% of those screened).
One of the 18 HCWs died of TB. Seventy-six percent (822/1082) of screened HCWs indicated that they already knew
their HIV status. Screening was considered feasible if confidentiality can be guaranteed although challenges such as the
time required for screening and sample transport were reported.
Conclusions: It is feasible to conduct and implement screening programs for TB among HCWs in hospitals and clinics,
and the notified incidence and yield is high. Advocacy is needed to educate managers and HCWs on the importance
of screening and the implementation of locally relevant screening algorithms. It is essential to ensure access to TB
infection control, diagnostics, treatment and confidential registration for HCW.
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Background
It has been proven that in many settings the burden of tu-
berculosis (TB) is two to four times higher among health
care workers (HCWs) than among the general population,
both in large reviews [1–3] and in studies published after
these reviews [4–7]. TB Surveillance among HCWs is
important, both to support individual HCWs with treat-
ment support and because it can be a proxy indicator for
infection control (IC) practices [8]. A limitation of this
indicator is that it can be influenced by the general health
status of the HCWs and their possible exposure to TB in
their community. It is essential to introduce national
policies that ensure priority access to TB care for HCWs,
and Provider Initiated Testing and Counselling (PITC) for
HIV [9, 10]. HCWs have been mentioned as a possible
risk group for screening in the World Health Organization
(WHO) guidelines on TB screening [11].
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The screening of HCWs for TB can lead to early case
detection and treatment, thereby reducing TB related
morbidity and mortality, worker absenteeism and hospi-
talizations, and helping to retain a healthy workforce.
Screening can also identify the areas in health facilities
where HCWs are most at risk by calculating in which
areas the proportion of HCW with TB over multiple
years is high. There is little evidence that the screening
of HCWs can reduce transmission [11], but in other risk
groups such as migrants, screening has proven to reduce
the severity of disease and has the potential to reduce
transmission [12, 13].
It is recommended to routinely screen HCWs for HIV,
not only after needle stick injuries [14]. HIV infected
HCWs should be moved to areas with less risk of TB
[9]. Several studies and the WHO recommend HIV
screening specifically for HCWs as part of routine occu-
pational health and safety activities [11, 15, 16].
In Zambia and most high TB burden countries, sur-
veillance of TB among HCW is only performed through
passive case finding [17]. In many African countries,
screening has not been implemented on a national scale
or under sustainable routine programme conditions,
with the exception of some hospitals and research pro-
jects [7, 10, 18]. In most countries the screening of
HCWs for TB does not happen at all or is limited to
pre-employment screening, usually consisting of chest x-
ray (CXR). There is also no routine screening for HIV or
other blood borne viruses. Before 2007, only 33% of the
HCWs in five Zambian hospitals had been tested for
HIV in a cross-sectional study [19], and the large major-
ity of HCWs feared getting infected with HIV in the
workplace [20]. Only one study on TB among HCWs in
Zambia was found. In this study a large university teach-
ing hospital in Zambia reported an increase in TB inci-
dence among nurses from 0.3% per year between 1982
and 1984 to 2.4% per year between 1999 and 2005 [21].
We conducted an evaluation with the aim of assessing
the feasibility and acceptance of HCW screening for TB
in a district setting that had different types of health
facilities, under routine programme conditions. The
specific objectives were to assess participation rate and
yield of screening for TB among HCWs. A secondary
objective was to assess what proportion of HCWs knew
their HIV status and had been tested for HIV in the last
year. To our knowledge, this is the first report from
Sub-Saharan Africa (outside South Africa), of an attempt
to implement district wide screening for TB among
HCWs, under programme conditions.
Methods
Country setting
In Zambia the estimated TB incidence in 2014 (the time
of the project) was 406/100,000, one of the highest in
the world, and this seems to be on the decline [22]. The
notification rate was 241/100,000 in 2014 [23]. Most
recent data show that the WHO estimated incidence
was 391/100,000 and the notification rate was 260/
100,000 in 2015 [24] . WHO estimated that 60% of all
TB patients were also co-infected with HIV [24].
TB control is implemented by the National TB control
Programme (NTP), under the Ministry of Health (MoH).
The national TB Infection Control (IC) guidelines include
the recommendation to remind HCWs and other staff
that they can develop TB and to ensure that they know
the signs and symptoms of TB and immediately report
such signs and symptoms to their supervisor [25].
District setting
This screening programme was part of a bigger project
introducing a combination of facility specific TB IC
interventions such as the triaging of patients and the
improvement of ventilation. The project took place in
the Ndola district in the Copperbelt Province of Zambia
[23] which has the second highest TB and HIV burden
in the country.
In the Ndola district the TB notification rate was 581/
100,000 population in 2013 [26], 465/100,000 in 2014,
374/100,000 in 2015 and 362/100,000 population in
2016 [personal communication, co-author MKS]. We
included the 15 largest health facilities with a TB diag-
nostic laboratory in the district, specifically the 13 larger
clinics, the provincial Ndola Central Hospital (NCH),
that includes an MDR-TB treatment facility and the re-
gional reference laboratory (Tropical Diseases Research
Centre, [TDRC]), and the Arthur Davison Children’s
hospital.
Design and participants
We used a cross-sectional design, in which each HCW
was intended to be screened once over the course of one
year. The participants were all staff working in the 15
facilities and included laboratory staff, administrative
staff, support staff such as cleaners and drivers, and reg-
istered TB community volunteers (who assist the health
facility with TB case finding and support TB patients
with taking treatment). For the purpose of this paper, all
were considered to be HCWs, as they all have an in-
creased risk of exposure to undiagnosed and/or diag-
nosed TB patients. As routine practice, HCWs were
encouraged to report to the assigned screener if they
had any TB related symptoms throughout the year.
Implementation steps
The project partners were: the Ministry of Health (MoH),
KNCV Tuberculosis Foundation, FHI 360, the Provincial
Medical Officer and the District Community Medical
Officer in Ndola. The first introductory meetings were held
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with the district leadership in order to introduce the screen-
ing of HCWs as part of the broader TB IC project. This
was essential to ensure ownership and sustainability of the
activities. Thereafter a baseline assessment was held that
consisted of structured individual interviews with leaders
from the NTP, the Provincial Medical Office, the District
Medical Office, facility heads (facility in-charges) and a con-
venience sample of HCWs from most of the participating
facilities. We sought to gather their opinions on the atti-
tudes, feasibility, acceptability, potential resources needs
and operational aspects of setting up a HCW TB screening
program. The results of these interviews were used to de-
velop the screening protocol and feedback on the proposed
screening tool and TB screening registers was recorded.
At least three group meetings (baseline, start-up, train-
ing) were held for all participating facility in-charges,
participants and screeners. Three additional visits were
made to each facility to explain procedures and provide
start-up support for the recording tools. At each clinic a
senior and trusted clinician was assigned by the facility-
in charge to perform the screening and keep the co-
nfidential records. The project provided supplies for
laboratory culture, chest X-ray (CXR) films, forms, box
files and lockable cabinets. The project partners made
regular visits to the clinics and hospitals to collect data
and discuss the results.
Screening
The screening was conducted from April 2013 to
May 2014 (Fig. 1). The facility in-charges ensured that
all the staff in their facilities were informed about the
programme, e.g. during staff meetings. Each HCW
was verbally invited for TB screening by the assigned
screener. The screener and HCW made an appointment
at a mutually convenient time. HCWs who had TB symp-
toms outside the screening appointment were encouraged
to contact the screener. The screener used a standard
short questionnaire which was administered face-to-face
in their own facility and in a confidential manner. The
questionnaire included questions on any TB symptoms
and their duration, TB contacts, HIV status, and past TB
disease. The participation rate in the screening was
considered a proxy for acceptance.
Those HCWs with symptoms (either during the screen-
ing appointment or before/after) were offered sputum
smear testing, as recommended by the NTP for any pre-
sumptive TB patient (previously called a TB suspect). Per-
sons with presumptive TB were referred by the screener
for sputum smear testing, with a request for two sputum
samples, a free service that is usually available in their
own facility. In addition, sputum was sent for culture at
the TDRC. Culture was carried out according to national
standards with external quality assurance by the national
reference laboratory. The presumptive TB patients were
also screened with a CXR at the NCH.
The Xpert® Mtb/Rif test (Xpert) which is a molecular
technology that simultaneously detects Mycobacterium
tuberculosis (Mtb) and Rifampicin resistance, became
available at two facilities including the NCH, in September
2013, midway through the study. Since then, the national
Fig. 1 Screening programme/algorithm for TB among HCW in Ndola district. TDRC = TB diagnostic and Research Centre; NCH = Ndola Central
Hospital; CXR = Chest x-ray
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TB diagnostic algorithm for Xpert included HCWs in
addition to people living with HIV, meaning culture could
be replaced by Xpert.
HCWs were also asked if they had been tested for HIV
in the previous year. Those not tested in the previous
year and not known to be positive were referred for
PITC. All presumptive TB patients and TB patients were
also offered PITC for HIV.
HCWs with TB were encouraged to disclose their TB
status to their facility-in charges following screening, as
this was not done by the screener. The total number of
HCWs diagnosed with TB during the period of the
screening programme was not available. The total num-
ber of HCWs diagnosed with TB during the calendar
year 2013 was used as an approximation of the HCWs
diagnosed during the 12 months of the screening
programme (April 2013 through May 2014). For com-
parison, the number of HCWs with TB in 2012 was also
recorded. These data were collected by interviewing the
facility in-charges.
Feasibility
Screeners and facility in-charges were individually inter-
viewed with open ended questions about the willingness
of HCWs to participate, the success factors and any
challenges which were encountered, including the time
needed for screening. Their answers to open questions
on success factors and challenges were frequency
counted and summarized by theme. The average time
needed for screening was analysed by facility type.
Data collection and analysis
A set of simple screening forms and aggregated summary
forms based upon an international guide were developed
[27]. The data were anonymized by a personal identifica-
tion number and all the forms containing personal iden-
tifiers were kept in a lockable cabinet in the facility,
provided by the project. One form (kept by the screener)
linked the name and address of the HCW with his or her
unique ID number to allow for the identification of the
participant if follow-up activities were required.
Aggregated summary reports were prepared by the
screener, with assistance from the District Community
Medical Office (DCMO) and project staff. These in-
cluded the number of HCWs screened by cadre and
facility, the reasons for non-response (if given), the num-
ber of presumptive TB patients, the type TB diagnostic
tests done, the number of HCWs diagnosed with TB and
starting TB treatment, the number of HCWs tested for
HIV in the last year, the number of HCWs who knew
their HIV status, and the number of HCWs who tested
HIV positive in the last year. Only aggregated summary
reports were collected by the project staff. They could not
access individual results. Aggregated data were entered
into an Excel spreadsheet and analysed by the researchers.
The participation rate was calculated by dividing the num-
ber of HCWs who were screened by the number of HCWs
employed (including registered community volunteers).
The yield was calculated in two ways: firstly by dividing
those with TB symptoms (presumptive TB patients) over
the number screened (presumptive TB yield), and sec-
ondly by dividing those diagnosed with TB by the number
of HCWs screened (TB disease yield). The notified inci-
dence was calculated as the total number of HCWs diag-
nosed with TB in a year divided by the number of
registered staff working in the facilities (paid and commu-
nity volunteers).
Results
Participation in screening
Between April 2013 and May 2014 a total of 1082
HCWs were screened for TB. The paid staff accounted
for 93% (1011/1082) of the total screened. There were
1619 paid staff and 138 community volunteers in the
participating facilities, a total of 1757. Therefore, 62%
(1011/ 1619) were screened out of the total paid staff
and 51% (71/138) were screened out of the community
volunteers. The mean participation rate (proportion, also
called coverage or proportion screened), was 254/454
(56%) from the 13 participating clinics; 723/952 (76%)
from NCH and 34/213 (16%) from the children’s
hospital (Table 1). The participation was between
50% and 70% for most cadres, except administrative
staff had a higher participation rate of 88% and clas-
sified daily employees (mainly cleaners) and labora-
tory staff had a lower participation rate of 47% and
37%, respectively (Fig. 2).
Yield of TB screening
There were 52 participants (4.8%) who were presumptive
TB cases out of those who were screened (1082), 4% in
hospitals and 10% in clinics (presumptive TB yield). Out
of those identified as presumptive TB patients, 31% (16/
52) had at least one sputum smear examination; 8% (4/
52) had culture examination done; 38% (20/52) got
Xpert tests and 73% (38/52) had a CXR. A total of 40
(77%) had at least one laboratory sputum test. Seventy-
three percent (38/52) of presumptive TB patients received
all diagnostic tests according to the agreed algorithm. The
summary reports that were prepared by the screener did
not contain a question on whether TB patients were
detected (first suspected) during the screening appoint-
ment, or had been found with presumptive TB already
before the screening, or later after the screening. We
attempted to collect this information by interviewing the
screening clinicians at the end of the project and found
that at least five TB patients among HCWs were detected
during the screening appointment, giving a yield of at least
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5/1082 = 0.5% (TB disease yield). One of these five HCWs
was a community volunteer.
Notified TB incidence
The total number of TB patients in calendar year 2013
was 18 out of the registered 1757 HCWs (paid and vol-
unteers) in the participating facilities. This indicated a
notified incidence rate among HCWs of 1% (95% CI
0.6–1.6). Although not all HCWs were diagnosed at the
specific screening appointment, the reported TB inci-
dence is considered a result of the screening programme
because HCWs were instructed to seek medical advice if
they experienced TB symptoms between screenings. All
18 patients were started on treatment according to the
national TB guidelines. As stated in the paragraph ‘yield
of TB screening’ at least five out of the 18 (28%) were
detected through screening and at least one of these was
a treatment supporter. It was not documented whether
the other 13 patients notified were detected during the
screening appointment or the routine passive surveil-
lance system, as the type of case detection (screening or
passive) was not part of the aggregated TB IC indicators
[27]. No drug-resistant TB was reported among HCWs
during the evaluation period. All18 HCWs with TB were
started on treatment, but one died from TB in 2013 be-
fore they completed treatment. The TB incidence among
HCWs in 2012 showed a similar incidence (0.9%).
HIV
Seventy-six percent (822/1082) of the HCWs who par-
ticipated in the evaluation indicated they already knew
their HIV status at the time of the screening appoint-
ment; among these 59% (485/822) had been tested in
the preceding year and 4% (19/485) of them were HIV
infected. Those who did not know their HIV status were
encouraged to go for PITC.
Feasibility
The screeners generally considered screening to be feas-
ible. Success factors mentioned were that HCWs were
well aware of the risk and were actually eager for a
screening programme to start. The assurance of confi-
dentiality was considered very important by HCWs. Re-
searchers observed that signed informed consent forms
were available for all the HCWs screened and screening
forms were kept in the locked cabinets. The assignment
of a trusted person as screener was mentioned as being
crucial factors of HCWs participating. In the hospital
Table 1 The proportion of HCWs screened, the yield and the TB incidence
Number of HCWs Number screened % Number (%) with symptoms
(presumptive TB)a
Number (%) with TBa
Total 1757 1082 62% 52 (5% of 1082) 18 (1% of 1757) of whom at least 5 (0.5% of 1082)
due to screening appointment
Type of HCW
Paid staff 1619 1011 62%
Volunteers 138 71 51%
Paid staff by type of facility
13 clinics 454 254 56%
Hospital 1 952 723 76%
Hospital 2 213 34 16%
aThese data are not provided by subgroups to protect confidentiality
Fig. 2 Percentage of health care workers screened in the 15 facilities by cadre. Between brackets the number of HCW employed in the
facilities by cadre
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with a large participation rate the screener went from
ward to ward to recruit HCWs for screening. Screeners
reported that only short times were needed to complete
the screenings (15–30 min in clinics and 15–20 min in
the main hospital).
Despite feasibility, challenges were also reported. The
screeners reported that in the hospitals the high number
of HCWs that needed to be screened took a large
proportion of their time, and therefore a dedicated
screening team may be needed. Screeners reported the
following reasons for non-participation: both the HCW
and screener were busy, the HCW had yet to make up
their mind, the HCW was screened elsewhere, some
HCWs were not willing to be screened. Screeners indi-
cated there may still be an issue with stigma when
HCWs choose not to get screened or to get screened
elsewhere, although stigma plays a smaller role than in
the past, when TB was strongly linked to HIV and no
anti-retroviral treatment was available. The reasons
given for not being screened could not be systematically
collected, as HCWs who did not attend often did so
without giving a reason. The children’s hospital screeners
(the facility with lowest participation rate) indicated that
finding suitable times for screening was a challenge. Some
mentioned that frequent staff turnover affected the par-
ticipation rate. When asked why the recommended
screening algorithm was not always followed, some
screeners indicated that they followed the national guide-
lines of awaiting the sputum smear result before perform-
ing other diagnostics. Challenges with the availability of
sample transportation were also frequently mentioned.
Discussion
We found that the introduction of screening for TB
among HCWs was feasible. Sixty-two percent (62%) of
HCWs were screened in the 15 facilities within one year,
5% of those screened had presumptive TB, at least 0.5%
of those screened had TB during the screening appoint-
ment, and the notified TB incidence among HCWs
during the screening programme was 1%. The main
challenges were the larger number of HCWs to be
screened in hospitals and the finding that only 73% of
presumptive TB patients had all the diagnostic tests
specified in the screening algorithm.
The proportion of HCWs screened (62%) is similar to
the weighted mean of five studies (59%) mentioned in
the WHO screening guidelines for TB [11] and confirms
less than optimal participation rates found in a system-
atic literature review in South Africa [7]. A high willing-
ness to be screened among HCWs was reported in
Johannesburg [4]. The large differences in participation
between facilities shows that acceptance is not universal,
and that stigma may still play a role [28, 29]. Although
participation was considered a proxy for acceptance, the
characteristics of the screener (for example availability,
responsibility, pro-activeness and seniority) and facility
management (sensitization, priority setting) may have in-
fluenced the participation rate. The lowest participation
rate was found in the children’s hospital, where finding a
suitable time for screening was mentioned as the main
reason. Screening in the children’s hospital was possibly
less of priority because children are less often smear-
positive, and therefore HCWs may have considered
themselves to be at a lower risk of infection.
The differences in participation rates between cadres
of staff (Fig. 2) shows that more effort is needed to
include classified daily employees (e.g., cleaners) and
laboratory staff. Classified daily employees may be less
aware of their risk than other HCWs. Laboratory
workers may be more affected by stigma since their
close colleagues would need to investigate their sputum
sample. The high participation rate among administra-
tive staff may be explained by sensitization. Screening at-
tendance may increase with two screeners per facility,
when it is integrated with screening for other diseases,
or when screening is provided in special HIV care treat-
ment programs for HCWs, as has been done in South
Africa and Malawi [30, 31], although there is very little
evidence for workplace screening programs for TB and
HIV for health care workers [32]. The number of HCW
in our study was too low to estimate incidence by cadre
but other studies found that some cadres are at higher
risk than others [2, 5].
In the recent nationwide prevalence survey 9.7% of the
participants had at least one TB symptom (defined as
presumptive TB), compared to our finding of 5% [32].
This may be a result of the so called healthy worker
effect [33].
When we assume that those screened are representa-
tive of all HCWs (which it may or may not be as we
didn’t use a probability based sample), then the finding
of 5% presumptive TB among HCWs, may result in
5%*1757 = 88 persons needing expensive diagnostic tests
(in this programme CXR and culture or Xpert). This is a
limited number of additional diagnostic tests compared
to the volume of such tests that is usually done in this
district. In the national guidelines, culture and CXR are
usually reserved for specific risk groups. Since the onset
of this programme HCW are one of these risk groups.
Further study on cost-effectiveness is needed.
The agreed screening algorithm was often not followed
by the screening clinicians, as shown by the low propor-
tion of HCWs with presumptive TB who had all the
diagnostic tests performed (77% had a laboratory test
and 73% had a CXR). The screening clinicians indicated
they tended to use the national algorithm for diagnosing
TB (starting with smear microscopy alone), and had chal-
lenges with sample transport to the facilities (1 culture
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and 2 Xpert sites). During baseline interviews before the
screening programme started, HCWs indicated that if they
had presumptive TB they were willing to cover their own
transport costs. The low proportion of HCWs with pre-
sumptive TB who had a laboratory test done may also be
due to stigma, as the test was often carried out in the
same facility where the they worked.
CXR is widely applied for presumptive TB patients in
Zambia, more often than in the national guidelines, there-
fore HCWs questioned why not all of them had an annual
CXR. Annual CXR screening would be an expensive inter-
vention (although perhaps cost-effective). It was only added
to the international screening guidelines for high incidence
settings after start of our programme [11]. The screening
algorithm to be selected is dependent on local epidemiology
of TB and HIV. Xpert is now available and is being scaled-
up in the country and is offered to all HCWs with symp-
toms as part of the national Xpert algorithm.
The results of HIV screening are challenging to inter-
pret as those who are already infected do not need to be
screened again. In our programme, HCWs who knew
they were HIV infected may have refused to participate
more often. Our results show that the proportion tested
has increased since a previous study in Zambia [19],
possibly because stigma has decreased. Our results also
show that TB screening is a possible entry for HIV
screening [34].
Strengths and limitations
The strength of this programme was that the leadership
was provided by the district management and by existing
government health care providers in facilities providing
the screening services. As opposed to a research setting,
this set-up was intended to be sustainable. The strength
of the evaluation was that a variety of facilities and a
large number of HCWs were included.
A limitation of the assessment was that data-analysis
from aggregated data gave limited results. For example
we did not always know reasons of refusal and reasons
why diagnostic tests were not done for individual HCW
were not always clear. Further, since the Guide on the
monitoring of TB disease incidence among health care
workers did not include an indicator on yield of TB
disease among screened HCW, this was not included
in our aggregated forms [27]. Future studies should
include this.
The agreed screening algorithm, that provided only
TB diagnostic tests for HCWs with symptoms, has one
main limitation, namely that the sensitivity of symptom
screening is low, varying from 49% for any cough to 84%
for any symptom [35].
The 1% notified incidence of TB among HCWs in
2013 might be an underestimate as it was based on ag-
gregated summary forms and interviews with facility in-
charges and therefore prone to recall bias. It is also un-
known whether non-responders had a higher risk of pre-
sumptive or active TB than those who were screened.
We may have missed TB patients who were diagnosed
and treated elsewhere and did not disclose their TB to
their facility in-charge. We expect that the majority of
TB patients among HCW will be detected between screen-
ing appointments, and that the screening programme has
increased awareness of the need to report symptoms early.
Other studies have found that HCW are at 2–4 times
increased risk of TB than the general population [1–6].
We could not confirm this, possibly due to the above
mentioned reasons.
Another limitation was that we could include only one
district. Further the screening period (April 2013–May
2014) was not exactly aligned with the calendar year for
which the total TB incidence among HCWs was avail-
able, but as TB is a slow epidemic we do not expect that
this difference will change our conclusions.
Conclusions
Screening for TB among HCWs can be implemented by
district and hospital management teams. The incidence
of TB among HCWs is high (1%), HCWs are willing to
be screened with a similar participation rate as reported
elsewhere (62%), the yield of screening is high (at least
0.5% of those screened had TB) and screening is feasible.
It takes time to build the buy-in of facility management
and screeners for the screening process and to imple-
ment the agreed screening algorithm, especially in large
facilities. The implementation of the diagnostic algo-
rithm needs more advocacy, explanation and follow-up
and the laboratory sample transport and tracking system
should be improved, for example by linking to existing
transport systems or by hiring a commercial partner. Re-
sources should be allocated to ensure access to infection
control, diagnostics, treatment, logistics and confidential
registration. Screening results should be included in dis-
trict reports. Non-paid staff such as community volun-
teers should be included in HCW screening. Alternative
models for screening should be investigated, such as
conducting screening by rotating screening teams.
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